There was an overall decrease in influenza vaccine uptake among United States adults from 2020 to 2024, according to study findings.

The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

Study reveals primary cause of obesity — and it's not lack of exercise Moment CNN contributor’s young son crashes tense ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

Moderna Inc. said its experimental flu shot showed positive results in a late-stage trial.

(The Hill) – Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...

The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every American but threw in a twist: Only use certain shots free of an ...